Douglass Winthrop Advisors’s Salarius Pharmaceuticals SLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-26
Closed -$117K 280
2021
Q1
$117K Hold
26
﹤0.01% 264
2020
Q4
$72K Hold
26
﹤0.01% 263
2020
Q3
$67K Hold
26
﹤0.01% 264
2020
Q2
$104K Hold
26
﹤0.01% 232
2020
Q1
$54K Hold
26
﹤0.01% 229
2019
Q4
$298K Hold
26
0.01% 230
2019
Q3
$429K Buy
+26
New +$429K 0.02% 192